Abstract
Patients with amyloidosis have decreased survival, unless novel disease modifying therapies are introduced. Early diagnosis improves survival and identification of at-risk populations is critical to improve outcomes. The epidemiology of amyloidosis in the US Veterans Health Administration is unknown. The objective of this project is to calculate the incidence of amyloidosis in the US Veterans Health Administration.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
